Another phosphorylated form of tau, p-Tau217, has been studied in AD and other neurodegenerative diseases such as bvFTD or PPA, finding an AUC of 0.92 with a specificity of 81% and sensitivity of 93% to differentiate between these variants of FTD and AD (173). This evidence concerns the gene MAPT and frontotemporal dementia.